BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mukai R, Handa O, Naito Y, Takayama S, Suyama Y, Ushiroda C, Majima A, Hirai Y, Mizushima K, Okayama T, Katada K, Kamada K, Uchiyama K, Ishikawa T, Takagi T, Itoh Y. High-Fat Diet Causes Constipation in Mice via Decreasing Colonic Mucus. Dig Dis Sci 2020;65:2246-53. [DOI: 10.1007/s10620-019-05954-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang H, Horiuchi Y, Hironao KY, Kitakaze T, Yamashita Y, Ashida H. Prevention effect of quercetin and its glycosides on obesity and hyperglycemia through activating AMPKα in high-fat diet-fed ICR mice. J Clin Biochem Nutr 2020;67:74-83. [PMID: 32801472 DOI: 10.3164/jcbn.20-47] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
2 Choi SI, Kim N, Nam RH, Park JH, Nho H, Yu JE, Song CH, Lee SM, Lee DH. Fecal Microbial Enterotypes Differentially Respond to a High-fat Diet Based on Sex in Fischer-344 Rats. J Cancer Prev 2021;26:277-88. [PMID: 35047454 DOI: 10.15430/JCP.2021.26.4.277] [Reference Citation Analysis]
3 Kim JE, Choi YJ, Lee SJ, Gong JE, Lim Y, Hong JT, Hwang DY. Molecular Characterization of Constipation Disease as Novel Phenotypes in CRISPR-Cas9-Generated Leptin Knockout Mice with Obesity. Int J Mol Sci 2020;21:E9464. [PMID: 33322729 DOI: 10.3390/ijms21249464] [Reference Citation Analysis]
4 Mu J, Zhao X, Zalan Z, Hegyi F, Takács K, Du M. Lactobacillus plantarum KFY02 enhances the relieving effect of gardenoside on montmorillonite induced constipation in mice. RSC Adv 2020;10:10368-81. [DOI: 10.1039/c9ra10446a] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Alemao CA, Budden KF, Gomez HM, Rehman SF, Marshall JE, Shukla SD, Donovan C, Forster SC, Yang IA, Keely S, Mann ER, El Omar EM, Belz GT, Hansbro PM. Impact of diet and the bacterial microbiome on the mucous barrier and immune disorders. Allergy 2021;76:714-34. [PMID: 32762040 DOI: 10.1111/all.14548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Naito Y, Ushiroda C, Mizushima K, Inoue R, Yasukawa Z, Abe A, Takagi T. Epigallocatechin-3-gallate (EGCG) attenuates non-alcoholic fatty liver disease via modulating the interaction between gut microbiota and bile acids. J Clin Biochem Nutr 2020;67:2-9. [PMID: 32801462 DOI: 10.3164/jcbn.20-39] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Jaber A, Hemmer S, Klotz R, Ferbert T, Hensel C, Eisner C, Ryang YM, Obid P, Friedrich K, Pepke W, Akbar M. Bowel dysfunction after elective spinal surgery: etiology, diagnostics and management based on the medical literature and experience in a university hospital. Orthopade 2021;50:425-34. [PMID: 33185695 DOI: 10.1007/s00132-020-04034-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Fernández-Tomé S, Ortega Moreno L, Chaparro M, Gisbert JP. Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:10224. [PMID: 34638564 DOI: 10.3390/ijms221910224] [Reference Citation Analysis]